The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dutasteride-Global Market Insights and Sales Trends 2025
Synopsis
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dutasteride in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Dutasteride market. Type I, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Type II segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Dutasteride market, driven by demand from China, the second largest economy with some signs of stabilising, the Dutasteride market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dutasteride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dutasteride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dutasteride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dutasteride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dutasteride covered in this report include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc.
The global Dutasteride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Global Dutasteride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dutasteride market, Segment by Type:
Type I
Type II
Global Dutasteride market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dutasteride in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Dutasteride market. Type I, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Type II segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Dutasteride market, driven by demand from China, the second largest economy with some signs of stabilising, the Dutasteride market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dutasteride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dutasteride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dutasteride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dutasteride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dutasteride covered in this report include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc.
The global Dutasteride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Global Dutasteride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dutasteride market, Segment by Type:
Type I
Type II
Global Dutasteride market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Dutasteride Market Overview
1.1 Dutasteride Product Overview
1.2 Dutasteride Market Segment by Type
1.2.1 Type I
1.2.2 Type II
1.3 Global Dutasteride Market Size by Type
1.3.1 Global Dutasteride Market Size Overview by Type (2018-2029)
1.3.2 Global Dutasteride Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dutasteride Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dutasteride Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dutasteride Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dutasteride Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dutasteride Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dutasteride Sales Breakdown by Type (2018-2023)
2 Global Dutasteride Market Competition by Company
2.1 Global Top Players by Dutasteride Sales (2018-2023)
2.2 Global Top Players by Dutasteride Revenue (2018-2023)
2.3 Global Top Players by Dutasteride Price (2018-2023)
2.4 Global Top Manufacturers Dutasteride Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dutasteride Market Competitive Situation and Trends
2.5.1 Dutasteride Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dutasteride Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dutasteride as of 2022)
2.7 Date of Key Manufacturers Enter into Dutasteride Market
2.8 Key Manufacturers Dutasteride Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dutasteride Status and Outlook by Region
3.1 Global Dutasteride Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dutasteride Historic Market Size by Region
3.2.1 Global Dutasteride Sales in Volume by Region (2018-2023)
3.2.2 Global Dutasteride Sales in Value by Region (2018-2023)
3.2.3 Global Dutasteride Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dutasteride Forecasted Market Size by Region
3.3.1 Global Dutasteride Sales in Volume by Region (2024-2029)
3.3.2 Global Dutasteride Sales in Value by Region (2024-2029)
3.3.3 Global Dutasteride Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dutasteride by Application
4.1 Dutasteride Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Dutasteride Market Size by Application
4.2.1 Global Dutasteride Market Size Overview by Application (2018-2029)
4.2.2 Global Dutasteride Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dutasteride Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dutasteride Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dutasteride Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dutasteride Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dutasteride Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dutasteride Sales Breakdown by Application (2018-2023)
5 North America Dutasteride by Country
5.1 North America Dutasteride Historic Market Size by Country
5.1.1 North America Dutasteride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dutasteride Sales in Volume by Country (2018-2023)
5.1.3 North America Dutasteride Sales in Value by Country (2018-2023)
5.2 North America Dutasteride Forecasted Market Size by Country
5.2.1 North America Dutasteride Sales in Volume by Country (2024-2029)
5.2.2 North America Dutasteride Sales in Value by Country (2024-2029)
6 Europe Dutasteride by Country
6.1 Europe Dutasteride Historic Market Size by Country
6.1.1 Europe Dutasteride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dutasteride Sales in Volume by Country (2018-2023)
6.1.3 Europe Dutasteride Sales in Value by Country (2018-2023)
6.2 Europe Dutasteride Forecasted Market Size by Country
6.2.1 Europe Dutasteride Sales in Volume by Country (2024-2029)
6.2.2 Europe Dutasteride Sales in Value by Country (2024-2029)
7 Asia-Pacific Dutasteride by Region
7.1 Asia-Pacific Dutasteride Historic Market Size by Region
7.1.1 Asia-Pacific Dutasteride Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dutasteride Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dutasteride Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dutasteride Forecasted Market Size by Region
7.2.1 Asia-Pacific Dutasteride Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dutasteride Sales in Value by Region (2024-2029)
8 Latin America Dutasteride by Country
8.1 Latin America Dutasteride Historic Market Size by Country
8.1.1 Latin America Dutasteride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dutasteride Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dutasteride Sales in Value by Country (2018-2023)
8.2 Latin America Dutasteride Forecasted Market Size by Country
8.2.1 Latin America Dutasteride Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dutasteride Sales in Value by Country (2024-2029)
9 Middle East and Africa Dutasteride by Country
9.1 Middle East and Africa Dutasteride Historic Market Size by Country
9.1.1 Middle East and Africa Dutasteride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dutasteride Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dutasteride Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dutasteride Forecasted Market Size by Country
9.2.1 Middle East and Africa Dutasteride Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dutasteride Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Dutasteride Products Offered
10.1.5 GSK Recent Development
10.2 Bionpharma
10.2.1 Bionpharma Company Information
10.2.2 Bionpharma Introduction and Business Overview
10.2.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bionpharma Dutasteride Products Offered
10.2.5 Bionpharma Recent Development
10.3 Rising Pharmaceuticals
10.3.1 Rising Pharmaceuticals Company Information
10.3.2 Rising Pharmaceuticals Introduction and Business Overview
10.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Rising Pharmaceuticals Dutasteride Products Offered
10.3.5 Rising Pharmaceuticals Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Dutasteride Products Offered
10.4.5 Teva Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Dutasteride Products Offered
10.5.5 Mylan Recent Development
10.6 Zydus
10.6.1 Zydus Company Information
10.6.2 Zydus Introduction and Business Overview
10.6.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zydus Dutasteride Products Offered
10.6.5 Zydus Recent Development
10.7 Amneal Pharma
10.7.1 Amneal Pharma Company Information
10.7.2 Amneal Pharma Introduction and Business Overview
10.7.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Amneal Pharma Dutasteride Products Offered
10.7.5 Amneal Pharma Recent Development
10.8 Apotex
10.8.1 Apotex Company Information
10.8.2 Apotex Introduction and Business Overview
10.8.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Apotex Dutasteride Products Offered
10.8.5 Apotex Recent Development
10.9 Marksans Pharma
10.9.1 Marksans Pharma Company Information
10.9.2 Marksans Pharma Introduction and Business Overview
10.9.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Marksans Pharma Dutasteride Products Offered
10.9.5 Marksans Pharma Recent Development
10.10 Breckenridge Pharmaceutical
10.10.1 Breckenridge Pharmaceutical Company Information
10.10.2 Breckenridge Pharmaceutical Introduction and Business Overview
10.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Breckenridge Pharmaceutical Dutasteride Products Offered
10.10.5 Breckenridge Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dutasteride Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dutasteride Industrial Chain Analysis
11.4 Dutasteride Market Dynamics
11.4.1 Dutasteride Industry Trends
11.4.2 Dutasteride Market Drivers
11.4.3 Dutasteride Market Challenges
11.4.4 Dutasteride Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dutasteride Distributors
12.3 Dutasteride Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
